On 30 November 2022, the technology company OpenAI released ChatGPT — a chatbot built to respond to prompts in a human-like manner. It has taken the scientific community and the public by storm, attracting one million users in the first 5 days alone; that number now totals more than 180 million. Seven researchers told Nature how it has changed their approach. Learn more
Computational approaches are emerging as powerful tools for the discovery of antibiotics. A study now uses machine learning to discover abaucin, a potent antibiotic that targets the bacterial pathogen Acinetobacter baumannii. Learn more